{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:19:55Z","timestamp":1787771995223,"version":"build-2784847793"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1116 B8"],"award-info":[{"award-number":["SFB 1116 B8"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1116 B8"],"award-info":[{"award-number":["SFB 1116 B8"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["CA 16225"],"award-info":[{"award-number":["CA 16225"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["IG16225"],"award-info":[{"award-number":["IG16225"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["IG16225"],"award-info":[{"award-number":["IG16225"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Whereas prior experiments in juvenile pigs had reported infarct size reduction by intravenous metoprolol early during myocardial ischaemia, two major clinical trials in patients with reperfused acute myocardial infarction were equivocal. We, therefore, went back and tested the translational robustness of infarct size reduction by metoprolol in minipigs. Using a power analysis-based prospective design, we pretreated 20 anaesthetised adult G\u00f6ttingen minipigs with 1\u00a0mg\u00a0kg<jats:sup>\u22121<\/jats:sup> metoprolol or placebo and subjected them to 60-min coronary occlusion and 180-min reperfusion. Primary endpoint was infarct size (triphenyl tetrazolium chloride staining) as a fraction of area at risk; no-reflow area (thioflavin-S staining) was a secondary endpoint. There was no significant reduction in infarct size (46\u2009\u00b1\u20098% of area at risk with metoprolol vs. 42\u2009\u00b1\u20098% with placebo) or area of no-reflow (19\u2009\u00b1\u200921% of infarct size with metoprolol vs. 15\u2009\u00b1\u200923% with placebo). However, the inverse relationship between infarct size and ischaemic regional myocardial blood flow was modestly, but significantly shifted downwards with metoprolol, whereas ischaemic blood flow tended to be reduced by metoprolol. With an additional dose of 1\u00a0mg\u00a0kg<jats:sup>\u22121<\/jats:sup> metoprolol after 30-min ischaemia in 4 additional pigs, infarct size was also not reduced (54\u2009\u00b1\u20099% vs. 46\u2009\u00b1\u20098% in 3 contemporary placebo, n.s.), and area of no-reflow tended to be increased (59\u2009\u00b1\u200920% vs. 29\u2009\u00b1\u200912%, n.s.).<\/jats:p><jats:p>Infarct size reduction by metoprolol in pigs is not robust, and this result reflects the equivocal clinical trials. The lack of infarct size reduction may be the result of opposite effects of reduced infarct size at any given blood flow and reduced blood flow, possibly through unopposed alpha-adrenergic coronary vasoconstriction.<\/jats:p>","DOI":"10.1007\/s00395-023-00993-4","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T13:03:07Z","timestamp":1686229387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult G\u00f6ttingen minipigs"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-3772","authenticated-orcid":false,"given":"Petra","family":"Kleinbongard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8631-3355","authenticated-orcid":false,"given":"Helmut Raphael","family":"Lieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8396-0450","authenticated-orcid":false,"given":"Andreas","family":"Skyschally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-4160","authenticated-orcid":false,"given":"Gerd","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"993_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-019-0732-3","volume":"114","author":"G Amanakis","year":"2019","unstructured":"Amanakis G, Kleinbongard P, Heusch G, Skyschally A (2019) Attenuation of ST-segment elevation after ischemic conditioning maneuvers reflects cardioprotection online. Basic Res Cardiol 114:22. https:\/\/doi.org\/10.1007\/s00395-019-0732-3","journal-title":"Basic Res Cardiol"},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1365-2362.1996.150293.x","volume":"26","author":"G Anfossi","year":"1996","unstructured":"Anfossi G, Trovati M (1996) Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur J Clin Invest 26:353\u2013370. https:\/\/doi.org\/10.1046\/j.1365-2362.1996.150293.x","journal-title":"Eur J Clin Invest"},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/cvr\/cvp033","volume":"83","author":"K Boengler","year":"2009","unstructured":"Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cardiovasc Res 83:247\u2013261. https:\/\/doi.org\/10.1093\/cvr\/cvp033","journal-title":"Cardiovasc Res"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-021-00874-8","volume":"116","author":"R Bolli","year":"2021","unstructured":"Bolli R (2021) CAESAR\u2019s legacy: a new era of rigor in preclinical studies of cardioprotection. Basic Res Cardiol 116:33. https:\/\/doi.org\/10.1007\/s00395-021-00874-8","journal-title":"Basic Res Cardiol"},{"key":"993_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00359-022-00964-1","volume":"117","author":"R Bolli","year":"2022","unstructured":"Bolli R, Tang XL (2022) New insights into cardioprotection, gained by adopting the CAESAR standards of rigor. Basic Res Cardiol 117:57. https:\/\/doi.org\/10.1007\/s00359-022-00964-1","journal-title":"Basic Res Cardiol"},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-022-00928-5","volume":"117","author":"F B\u00f6nner","year":"2022","unstructured":"B\u00f6nner F, Gastl M, Nienhaus F, Rothe M, Jahn A, Pfeiler S, Gross U, Schultheiss HP, Ibanez B, Kozerke S, Szendroedi J, Roden M, Westenfeld R, Schrader J, Fl\u00f6gel U, Heusch G, Kelm M (2022) Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo (19)F cardiovascular magnetic resonance in pigs. Basic Res Cardiol 117:21. https:\/\/doi.org\/10.1007\/s00395-022-00928-5","journal-title":"Basic Res Cardiol"},{"key":"993_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE B\u00f8tker","year":"2018","unstructured":"B\u00f8tker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schl\u00fcter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https:\/\/doi.org\/10.1007\/s00395-018-0696-8","journal-title":"Basic Res Cardiol"},{"key":"993_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.117.312586","volume":"122","author":"KM Broughton","year":"2018","unstructured":"Broughton KM, Wang BJ, Firouzi F, Khalafalla F, Dimmeler S, Fernandez-Aviles F, Sussman MA (2018) Mechanisms of Cardiac Repair and Regeneration. Circ Res 122:1151\u20131163. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312586","journal-title":"Circ Res"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijcard.2010.08.018","volume":"153","author":"G Cimmino","year":"2011","unstructured":"Cimmino G, Ibanez B, Giannarelli C, Prat-Gonzalez S, Hutter R, Garcia M, Sanz J, Fuster V, Badimon JJ (2011) Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol. Int J Cardiol 153:256\u2013261. https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.018","journal-title":"Int J Cardiol"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","volume":"41","author":"A Clemente-Morag\u00f3n","year":"2020","unstructured":"Clemente-Morag\u00f3n A, G\u00f3mez-Tech M, Villena-Gutierrez R, Lalama Tech DV, Garc\u00eda-Prieto J, Mart\u00ednez F, S\u00e1nchez-Cabo F, Fuster V, Oliver E, Ib\u00e1nez B (2020) Metoprolol exerts a non-class effect against ischemia-reperfusion injury by abrogating exacerbated inflammation. Eur Heart J 41:4425\u20134440. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa733","journal-title":"Eur Heart J"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1067\/mhj.2002.125618","volume":"144","author":"HA Cooper","year":"2002","unstructured":"Cooper HA, de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Gibson CM, Antman EM, Braunwald E (2002) Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. Am Heart J 144:790\u2013795. https:\/\/doi.org\/10.1067\/mhj.2002.125618","journal-title":"Am Heart J"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1111\/bph.15867","volume":"179","author":"MJ Curtis","year":"2022","unstructured":"Curtis MJ, Alexander SPH, Cirino G, George CH, Kendall DA, Insel PA, Izzo AA, Ji Y, Panettieri RA, Patel HH, Sobey CG, Stanford SC, Stanley P, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Ahluwalia A (2022) Declaration of transparency and scientific rigour: Checklist for design and analysis 2022. Br J Pharmacol 179:3914. https:\/\/doi.org\/10.1111\/bph.15867","journal-title":"Br J Pharmacol"},{"key":"993_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/01.cir.65.3.508","volume":"65","author":"LW DeBoer","year":"1982","unstructured":"DeBoer LW, Nosta JJ, Kloner RA, Braunwald E (1982) Studies of amiodarone during experimental myocardial infarction: beneficial effects on hemodynamics and infarct size. Circulation 65:508\u2013512. https:\/\/doi.org\/10.1161\/01.cir.65.3.508","journal-title":"Circulation"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-021-00884-6","volume":"116","author":"R Diaz-Munoz","year":"2021","unstructured":"Diaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, Pizarro G, Garcia-Rubira JC, Escalera N, Fuster V, Fernandez-Jimenez R, Ibanez B (2021) Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study. Basic Res Cardiol 116:45. https:\/\/doi.org\/10.1007\/s00395-021-00884-6","journal-title":"Basic Res Cardiol"},{"key":"993_CR15","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1161\/01.RES.82.12.1312","volume":"82","author":"DJ Duncker","year":"1998","unstructured":"Duncker DJ, Stubenitsky R, Verdouw PD (1998) Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise. Evidence for feed-forward \u00df-adrenergic control. Circ Res 82:1312\u20131322. https:\/\/doi.org\/10.1161\/01.RES.82.12.1312","journal-title":"Circ Res"},{"key":"993_CR16","doi-asserted-by":"publisher","first-page":"H981","DOI":"10.1152\/ajpheart.00977.2004","volume":"288","author":"G Ertl","year":"2005","unstructured":"Ertl G, Frantz S (2005) Wound model of myocardial infarction. Am J Physiol Heart Circ Physiol 288:H981\u2013H983. https:\/\/doi.org\/10.1152\/ajpheart.00977.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"993_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","volume":"75","author":"P Ferdinandy","year":"2023","unstructured":"Ferdinandy P, Andreadou I, Baxter GF, B\u00f8tker HE, Davidson SM, Dobrev D, Gersh BJ, Heusch G, Lecour S, Ruiz-Meana M, Zuurbier CJ, Hausenloy DJ, Schulz R (2023) Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol Rev 75:159\u2013216. https:\/\/doi.org\/10.1124\/pharmrev.121.000348","journal-title":"Pharmacol Rev"},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.116.025582","volume":"136","author":"R Fernandez-Jimenez","year":"2017","unstructured":"Fernandez-Jimenez R, Barreiro-Perez M, Martin-Garcia A, Sanchez-Gonzalez J, Aguero J, Galan-Arriola C, Garcia-Prieto J, Diaz-Pelaez E, Vara P, Martinez I, Zamarro I, Garde B, Sanz J, Fuster V, Sanchez PL, Ibanez B (2017) Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage. Circulation 136:1288\u20131300. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025582","journal-title":"Circulation"},{"key":"993_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cophys.2017.09.001","volume":"1","author":"NG Frangogiannis","year":"2018","unstructured":"Frangogiannis NG (2018) Cell biological mechanisms in regulation of the post-infarction inflammatory response. Curr Opin Physiol 1:7\u201313. https:\/\/doi.org\/10.1016\/j.cophys.2017.09.001","journal-title":"Curr Opin Physiol"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0008-6363(01)00434-5","volume":"53","author":"NG Frangogiannis","year":"2002","unstructured":"Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53:31\u201347. https:\/\/doi.org\/10.1016\/s0008-6363(01)00434-5","journal-title":"Cardiovasc Res"},{"key":"993_CR21","doi-asserted-by":"publisher","first-page":"14780","DOI":"10.1038\/ncomms14780","volume":"8","author":"J Garcia-Prieto","year":"2017","unstructured":"Garcia-Prieto J, Villena-Gutierrez R, Gomez M, Bernardo E, Pun-Garcia A, Garcia-Lunar I, Crainiciuc G, Fernandez-Jimenez R, Sreeramkumar V, Bourio-Martinez R, Garcia-Ruiz JM, Del Valle AS, Sanz-Rosa D, Pizarro G, Fernandez-Ortiz A, Hidalgo A, Fuster V, Ibanez B (2017) Neutrophil stunning by metoprolol reduces infarct size. Nat Commun 8:14780. https:\/\/doi.org\/10.1038\/ncomms14780","journal-title":"Nat Commun"},{"key":"993_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","volume":"67","author":"JM Garcia-Ruiz","year":"2016","unstructured":"Garcia-Ruiz JM, Fernandez-Jimenez R, Garcia-Alvarez A, Pizarro G, Galan-Arriola C, Fernandez-Friera L, Mateos A, Nuno-Ayala M, Aguero J, Sanchez-Gonzalez J, Garcia-Prieto J, Lopez-Melgar B, Martinez-Tenorio P, Lopez-Martin GJ, Macias A, Perez-Asenjo B, Cabrera JA, Fernandez-Ortiz A, Fuster V, Ibanez B (2016) Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol 67:2093\u20132104. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.050","journal-title":"J Am Coll Cardiol"},{"key":"993_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","volume":"58","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58:1833\u20131843. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.058","journal-title":"J Am Coll Cardiol"},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41569-018-0061-5","volume":"15","author":"NA Gude","year":"2018","unstructured":"Gude NA, Broughton KM, Firouzi F, Sussman MA (2018) Cardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence. Nat Rev Cardiol 15:523\u2013542. https:\/\/doi.org\/10.1038\/s41569-018-0061-5","journal-title":"Nat Rev Cardiol"},{"key":"993_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.res.60.5.738","volume":"60","author":"BD Guth","year":"1987","unstructured":"Guth BD, Heusch G, Seitelberger R, Ross J Jr (1987) Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 60:738\u2013746. https:\/\/doi.org\/10.1161\/01.res.60.5.738","journal-title":"Circ Res"},{"key":"993_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/01.cir.75.3.661","volume":"75","author":"BD Guth","year":"1987","unstructured":"Guth BD, Heusch G, Seitelberger R, Ross J Jr (1987) Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 75:661\u2013669. https:\/\/doi.org\/10.1161\/01.cir.75.3.661","journal-title":"Circulation"},{"key":"993_CR27","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/eurheartj\/ehz898","volume":"41","author":"A Haider","year":"2020","unstructured":"Haider A, Bengs S, Luu J, Osto E, Siller-Matula JM, Muka T, Gebhard C (2020) Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J 41:1328\u20131336. https:\/\/doi.org\/10.1093\/eurheartj\/ehz898","journal-title":"Eur Heart J"},{"key":"993_CR28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","volume":"153","author":"G Heusch","year":"2008","unstructured":"Heusch G (2008) Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol 153:1589\u20131601. https:\/\/doi.org\/10.1038\/sj.bjp.0707673","journal-title":"Br J Pharmacol"},{"key":"993_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","volume":"381","author":"G Heusch","year":"2013","unstructured":"Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166\u2013175. https:\/\/doi.org\/10.1016\/S0140-6736(12)60916-7","journal-title":"Lancet"},{"key":"993_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch G (2017) Critical issues for the translation of cardioprotection. Circ Res 120:1477\u20131486. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310820","journal-title":"Circ Res"},{"key":"993_CR31","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/eurheartj\/ehy253","volume":"39","author":"G Heusch","year":"2018","unstructured":"Heusch G (2018) Cardioprotection research must leave its comfort zone. Eur Heart J 39:3393\u20133395. https:\/\/doi.org\/10.1093\/eurheartj\/ehy253","journal-title":"Eur Heart J"},{"key":"993_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","volume":"114","author":"G Heusch","year":"2019","unstructured":"Heusch G (2019) Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol 114:45. https:\/\/doi.org\/10.1007\/s00395-019-0756-8","journal-title":"Basic Res Cardiol"},{"key":"993_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"993_CR34","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/eurheartj\/ehad160","volume":"44","author":"G Heusch","year":"2023","unstructured":"Heusch G, B\u00f8tker EH, Ferdinandy P, Schulz R (2023) Primordial non-responsiveness \u2013 a novel obstacle to cardioprotection. Eur Heart J 44:1687\u20131689. https:\/\/doi.org\/10.1093\/eurheartj\/ehad160","journal-title":"Eur Heart J"},{"key":"993_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0165-1838(85)90020-7","volume":"13","author":"G Heusch","year":"1985","unstructured":"Heusch G, Deussen A, Th\u00e4mer V (1985) Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia. J Auton Nerv Syst 13:311\u2013326. https:\/\/doi.org\/10.1016\/0165-1838(85)90020-7","journal-title":"J Auton Nerv Syst"},{"key":"993_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCULATIONAHA.119.044176","volume":"141","author":"G Heusch","year":"2020","unstructured":"Heusch G, Gersh BJ (2020) Is cardioprotection salvageable? Circulation 141:415\u2013417. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044176","journal-title":"Circulation"},{"key":"993_CR37","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1093\/eurheartj\/ehaa764","volume":"41","author":"G Heusch","year":"2020","unstructured":"Heusch G, Kleinbongard P (2020) Is metoprolol more cardioprotective than other beta-blockers? Eur Heart J 41:4441\u20134443. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa764","journal-title":"Eur Heart J"},{"key":"993_CR38","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","volume":"383","author":"G Heusch","year":"2014","unstructured":"Heusch G, Libby P, Gersh B, Yellon D, B\u00f6hm M, Lopaschuk G, Opie L (2014) Cardiovascular remodeling in coronary artery disease and heart failure. Lancet 383:1933\u20131943. https:\/\/doi.org\/10.1016\/S0140-6736(14)60107-0","journal-title":"Lancet"},{"key":"993_CR39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.yjmcc.2011.02.016","volume":"50","author":"G Heusch","year":"2011","unstructured":"Heusch G, Skyschally A, Schulz R (2011) The in-situ pig heart with regional ischemia\/reperfusion - ready for translation. J Mol Cell Cardiol 50:951\u2013963. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.02.016","journal-title":"J Mol Cell Cardiol"},{"key":"993_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/01.cir.82.2.595","volume":"82","author":"JW Homeister","year":"1990","unstructured":"Homeister JW, Hoff PT, Fletcher DD, Lucchesi BR (1990) Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 82:595\u2013608. https:\/\/doi.org\/10.1161\/01.cir.82.2.595","journal-title":"Circulation"},{"key":"993_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijcard.2009.09.551","volume":"147","author":"B Ibanez","year":"2011","unstructured":"Ibanez B, Cimmino G, Prat-Gonzalez S, Vilahur G, Hutter R, Garcia MJ, Fuster V, Sanz J, Badimon L, Badimon JJ (2011) The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol 147:428\u2013432. https:\/\/doi.org\/10.1016\/j.ijcard.2009.09.551","journal-title":"Int J Cardiol"},{"key":"993_CR42","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"B Ibanez","year":"2013","unstructured":"Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L, Mateos A, Fernandez-Ortiz A, Garcia-Ruiz JM, Garcia-Alvarez A, Iniguez A, Jimenez-Borreguero J, Lopez-Romero P, Fernandez-Jimenez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vazquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Perez PA, Fernandez-Campos MJ, Casado I, Garcia-Rubira JC, Garcia-Prieto J, Sanz-Rosa D, Cuellas C, Hernandez-Antolin R, Albarran A, Fernandez-Vazquez F (2013) Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial. Circulation 128:1495\u20131503. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003653","journal-title":"Circulation"},{"key":"993_CR43","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1161\/CIRCULATIONAHA.106.679639","volume":"115","author":"B Ibanez","year":"2007","unstructured":"Ibanez B, Prat-Gonzalez S, Speidl WS, Vilahur G, Pinero A, Cimmino G, Garcia MJ, Fuster V, Sanz J, Badimon JJ (2007) Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 115:2909\u20132916. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.679639","journal-title":"Circulation"},{"key":"993_CR44","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/0002-8703(95)90310-0","volume":"129","author":"KB Kern","year":"1995","unstructured":"Kern KB, Hilwig RW, Warner A, Basnight M, Ewy GA (1995) Failure of intravenous metropolol to limit acute myocardial infarct size in a nonreperfused porcine model. Am Heart J 129:650\u2013655. https:\/\/doi.org\/10.1016\/0002-8703(95)90310-0","journal-title":"Am Heart J"},{"key":"993_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00395-020-0814-2","volume":"115","author":"P Kleinbongard","year":"2020","unstructured":"Kleinbongard P (2020) Cardioprotection by early metoprolol attenuation of ischemic vs reperfusion injury? Basic Res Cardiol 115:54. https:\/\/doi.org\/10.1007\/s00395-020-0814-2","journal-title":"Basic Res Cardiol"},{"key":"993_CR46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/CIRCRESAHA.118.312784","volume":"122","author":"P Kleinbongard","year":"2018","unstructured":"Kleinbongard P, Amanakis G, Skyschally A, Heusch G (2018) Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: Evidence for cardioprotection from ischemic injury. Circ Res 122:1102\u20131108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312784","journal-title":"Circ Res"},{"key":"993_CR47","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1111\/bph.14839","volume":"177","author":"P Kleinbongard","year":"2020","unstructured":"Kleinbongard P, B\u00f8tker HE, Ovize M, Hausenloy DJ, Heusch G (2020) Co-morbidities and co-medications as confounders of cardioprotection - does it matter in the clinical setting? Br J Pharmacol 177:5252\u20135269. https:\/\/doi.org\/10.1111\/bph.14839","journal-title":"Br J Pharmacol"},{"key":"993_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/cvr\/cvac062","volume":"119","author":"P Kleinbongard","year":"2023","unstructured":"Kleinbongard P, Lieder H, Skyschally A, Heusch G (2023) No sex-related differences in infarct size, no-reflow and protection by ischaemic preconditioning in G\u00f6ttingen minipigs. Cardiovasc Res 119:561\u2013570. https:\/\/doi.org\/10.1093\/cvr\/cvac062","journal-title":"Cardiovasc Res"},{"key":"993_CR49","doi-asserted-by":"publisher","first-page":"1173462","DOI":"10.3389\/fcvm.2023.1173462","volume":"10","author":"P Kleinbongard","year":"2023","unstructured":"Kleinbongard P, Lieder H, Skyschally A, Heusch G (2023) Diazoxide is a powerful cardioprotectant but not feasible in a realistic infarct scenario. Front Cardiovasc Med 10:1173462. https:\/\/doi.org\/10.3389\/fcvm.2023.1173462","journal-title":"Front Cardiovasc Med"},{"key":"993_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00395-022-00965-0","volume":"117","author":"P Kleinbongard","year":"2022","unstructured":"Kleinbongard P, Lieder HR, Skyschally A, Alloosh M, G\u00f6decke A, Rahmann S, Sturek M, Heusch G (2022) Non-responsiveness to cardioprotection by ischaemic preconditioning in ossabaw minipigs with genetic predisposition to, but without the phenotype of the metabolic syndrome. Basic Res Cardiol 117:58. https:\/\/doi.org\/10.1007\/s00395-022-00965-0","journal-title":"Basic Res Cardiol"},{"key":"993_CR51","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0002-9149(01)01981-6","volume":"88","author":"RA Kloner","year":"2001","unstructured":"Kloner RA, Das S, Poole K, Perrit R, Muller J, Cannon CP, Braunwald E (2001) Seasonal variation of myocardial infarct size. Am J Cardiol 88:1021\u20131024. https:\/\/doi.org\/10.1016\/S0002-9149(01)01981-6","journal-title":"Am J Cardiol"},{"key":"993_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1399-6576.2011.02585.x","volume":"56","author":"E Kottenberg","year":"2012","unstructured":"Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J (2012) Protection by remote ischaemic preconditioning during coronary artery bypass grafting with isoflurane but not with propofol anesthesia - a clinical trial. Acta Anaesthesiol Scand 56:30\u201338. https:\/\/doi.org\/10.1111\/j.1399-6576.2011.02585.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"993_CR53","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/01.CIR.83.3.974","volume":"83","author":"P Kowallik","year":"1991","unstructured":"Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G (1991) Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 83:974\u2013982. https:\/\/doi.org\/10.1161\/01.CIR.83.3.974","journal-title":"Circulation"},{"key":"993_CR54","doi-asserted-by":"publisher","first-page":"e14810","DOI":"10.14814\/phy2.14810","volume":"9","author":"TR Lassen","year":"2021","unstructured":"Lassen TR, Hjortbak MV, Hauerslev M, Tonnesen PT, Kristiansen SB, Jensen RV, Botker HE (2021) Influence of strain, age, origin, and anesthesia on the cardioprotective efficacy by local and remote ischemic conditioning in an ex vivo rat model. Physiol Rep 9:e14810. https:\/\/doi.org\/10.14814\/phy2.14810","journal-title":"Physiol Rep"},{"key":"993_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-021-00893-5","volume":"116","author":"S Lecour","year":"2021","unstructured":"Lecour S, Andreadou I, B\u00f8tker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ (2021) IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-Cardioprotection cost action. Basic Res Cardiol 116:52. https:\/\/doi.org\/10.1007\/s00395-021-00893-5","journal-title":"Basic Res Cardiol"},{"key":"993_CR56","doi-asserted-by":"publisher","first-page":"H1365","DOI":"10.1152\/ajpheart.00580.2022","volume":"323","author":"HR Lieder","year":"2022","unstructured":"Lieder HR, Skyschally A, Sturek M, Heusch G, Kleinbongard P (2022) Remote ischemic conditioning in Ossabaw minipigs induces the release of humoral cardioprotective triggers, but the myocardium does not respond with reduced infarct size. Am J Physiol Heart Circ Physiol 323:H1365\u2013H1375. https:\/\/doi.org\/10.1152\/ajpheart.00580.2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"993_CR57","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey ML, Bolli R, Canty JM, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner R, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G (2018) Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 314:H812\u2013H838. https:\/\/doi.org\/10.1152\/ajpheart.00335.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"993_CR58","doi-asserted-by":"publisher","first-page":"H819","DOI":"10.1152\/ajpheart.00418.2021","volume":"321","author":"ML Lindsey","year":"2021","unstructured":"Lindsey ML, LeBlanc AJ, Ripplinger CM, Carter JR, Kirk JA, Hansell Keehan K, Brunt KR, Kleinbongard P, Kassiri Z (2021) Reinforcing rigor and reproducibility expectations for use of sex and gender in cardiovascular research. Am J Physiol Heart Circ Physiol 321:H819\u2013H824. https:\/\/doi.org\/10.1152\/ajpheart.00418.2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"993_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00395-020-0812-4","volume":"115","author":"M Lobo-Gonzalez","year":"2020","unstructured":"Lobo-Gonzalez M, Galan-Arriola C, Rossello X, Gonzalez-Del-Hoyo M, Vilchez JP, Higuero-Verdejo MI, Garcia-Ruiz JM, Lopez-Martin GJ, Sanchez-Gonzalez J, Oliver E, Pizarro G, Fuster V, Ibanez B (2020) Metoprolol blunts the time-dependent progression of infarct size. Basic Res Cardiol 115:55. https:\/\/doi.org\/10.1007\/s00395-020-0812-4","journal-title":"Basic Res Cardiol"},{"key":"993_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cvr\/cvw024","volume":"110","author":"Y Ma","year":"2016","unstructured":"Ma Y, Yabluchanskiy A, Iyer RP, Cannon PL, Flynn ER, Jung M, Henry J, Cates CA, Deleon-Pennell KY, Lindsey ML (2016) Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res 110:51\u201361. https:\/\/doi.org\/10.1093\/cvr\/cvw024","journal-title":"Cardiovasc Res"},{"key":"993_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/01.cir.43.1.67","volume":"43","author":"PR Maroko","year":"1971","unstructured":"Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, Braunwald E (1971) Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43:67\u201382. https:\/\/doi.org\/10.1161\/01.cir.43.1.67","journal-title":"Circulation"},{"key":"993_CR62","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124\u20131136. https:\/\/doi.org\/10.1161\/01.CIR.74.5.1124","journal-title":"Circulation"},{"key":"993_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","volume":"125","author":"G Niccoli","year":"2019","unstructured":"Niccoli G, Montone R, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy D, Berry C, Stiermaier T, Camici P, Eitel I (2019) Optimized treatment of ST-elevation myocardial infarction: The unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. Circ Res 125:245\u2013258. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315344","journal-title":"Circ Res"},{"key":"993_CR64","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines. PLoS Biol 18:e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411","journal-title":"PLoS Biol"},{"key":"993_CR65","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The Arrive guidelines 20: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"key":"993_CR66","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","volume":"63","author":"G Pizarro","year":"2014","unstructured":"Pizarro G, Fernandez-Friera L, Fuster V, Fernandez-Jimenez R, Garcia-Ruiz JM, Garcia-Alvarez A, Mateos A, Barreiro MV, Escalera N, Rodriguez MD, De MA, Garcia-Lunar I, Parra-Fuertes JJ, Sanchez-Gonzalez J, Pardillos L, Nieto B, Jimenez A, Abejon R, Bastante T, De V, Cabrera JA, Lopez-Melgar B, Guzman G, Garcia-Prieto J, Mirelis JG, Zamorano JL, Albarran A, Goicolea J, Escaned J, Pocock S, Iniguez A, Fernandez-Ortiz A, Sanchez-Brunete V, Macaya C, Ibanez B (2014) Long term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial. J Am Coll Cardiol 63:2356\u20132362. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.014","journal-title":"J Am Coll Cardiol"},{"key":"993_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjcard.2020.07.037","volume":"133","author":"T Podlesnikar","year":"2020","unstructured":"Podlesnikar T, Pizarro G, Fernandez-Jimenez R, Montero-Cabezas JM, Sanchez-Gonzalez J, Bucciarelli-Ducci C, Ajmone Marsan N, Fras Z, Bax JJ, Fuster V, Ibanez B, Delgado V (2020) Five-year outcomes and prognostic value of feature-tracking cardiovascular magnetic resonance in patients receiving early prereperfusion metoprolol in acute myocardial infarction. Am J Cardiol 133:39\u201347. https:\/\/doi.org\/10.1016\/j.amjcard.2020.07.037","journal-title":"Am J Cardiol"},{"key":"993_CR68","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","volume":"67","author":"V Roolvink","year":"2016","unstructured":"Roolvink V, Ibanez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A, Dambrink JHE, Escalera N, Lipsic E, Albarran A, Fern\u00e1ndez-Ortiz A, Fern\u00e1ndez-Avil\u00e9s F, Goicolea J, Botas J, Remkes W, Hernandez-Jaras V, Kedhi E, Zamorano JL, Navarro F, Alfonso F, Garc\u00eda-Lled\u00f3 A, Alonso J, van Leeuwen M, Nijveldt R, Postma S, Kolkman E, Gosselink M, de Smet B, Rasoul S, Piek JJ, Fuster V (2016) Early administration of intravenous beta blockers in patients with ST-elevation myocardial infarction before primary PCI. J Am Coll Cardiol 67:2705\u20132715. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.522","journal-title":"J Am Coll Cardiol"},{"key":"993_CR69","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4244\/EIJ-D-17-00776","volume":"14","author":"V Roolvink","year":"2018","unstructured":"Roolvink V, Ottervanger JP, Ibanez B, Dambrink JH, Gosselink M, Kedhi E, van Royen N, Lipsic E, Remkes W, Piek J, Fuster V, van \u2019t Hof A, (2018) One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion. EuroIntervention 14:688\u2013691. https:\/\/doi.org\/10.4244\/EIJ-D-17-00776","journal-title":"EuroIntervention"},{"key":"993_CR70","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.118.312939","volume":"122","author":"X Rossello","year":"2018","unstructured":"Rossello X, Ibanez B (2018) Infarct size reduction by targeting ischemic injury: Back to square one. Circ Res 122:1041\u20131043. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312939","journal-title":"Circ Res"},{"key":"993_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad024,10.1093\/cvr\/cvad024","author":"NV Sayour","year":"2023","unstructured":"Sayour NV, Brenner GB, Makkos A, Kiss B, Kov\u00e1csh\u00e1zi C, Gergely TG, Aukrust SG, Tian H, Zenkl V, G\u00f6m\u00f6ri K, Szabados T, Bencsik P, Heinen A, Schulz R, Baxter GF, Zuurbier CJ, Vok\u00f3 Z, Ferdinandy P, Giricz Z (2023) Cardioprotective efficacy of limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-centre in vivo study. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvad024,10.1093\/cvr\/cvad024","journal-title":"Cardiovasc Res"},{"key":"993_CR72","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/BF00169459","volume":"342","author":"R Schulz","year":"1990","unstructured":"Schulz R, Oudiz RJ, Guth BD, Heusch G (1990) Minimal a1- and a2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine. Naunyn Schmiedebergs Arch Pharmacol 342:422\u2013428. https:\/\/doi.org\/10.1007\/BF00169459","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"993_CR73","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00005344-199502000-00006","volume":"25","author":"R Schulz","year":"1995","unstructured":"Schulz R, Rose J, Skyschally A, Heusch G (1995) Bradycardic agent UL-FS 49 attenuates ischemic regional dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. J Cardiovasc Pharmacol 25:216\u2013228. https:\/\/doi.org\/10.1097\/00005344-199502000-00006","journal-title":"J Cardiovasc Pharmacol"},{"key":"993_CR74","doi-asserted-by":"publisher","first-page":"H871","DOI":"10.1152\/ajpheart.00293.2017","volume":"313","author":"A Skyschally","year":"2017","unstructured":"Skyschally A, Amanakis G, Neuh\u00e4user M, Kleinbongard P, Heusch G (2017) Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning. Am J Physiol Heart Circ Physiol 313:H871\u2013H878. https:\/\/doi.org\/10.1152\/ajpheart.00293.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"993_CR75","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10557-011-6300-1","volume":"25","author":"A Skyschally","year":"2011","unstructured":"Skyschally A, Heusch G (2011) Reduction of myocardial infarct size by dronedarone in pigs-a pleiotropic action? Cardiovasc Drugs Ther 25:197\u2013201. https:\/\/doi.org\/10.1007\/s10557-011-6300-1","journal-title":"Cardiovasc Drugs Ther"},{"key":"993_CR76","doi-asserted-by":"publisher","first-page":"919454","DOI":"10.3389\/fvets.2022.919454","volume":"9","author":"N Solanes","year":"2022","unstructured":"Solanes N, Bobi J, Arrieta M, Jimenez FR, Palacios C, Rodriguez JJ, Roque M, Galan-Arriola C, Ibanez B, Freixa X, Garcia-Alvarez A, Sabate M, Rigol M (2022) An open secret in porcine acute myocardial infarction models: The relevance of anaesthetic regime and breed in ischaemic outcomes. Front Vet Sci. 9:919454. https:\/\/doi.org\/10.3389\/fvets.2022.919454","journal-title":"Front Vet Sci."},{"key":"993_CR77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00395-021-00875-7","volume":"116","author":"HM Te Lintel","year":"2021","unstructured":"Te Lintel HM, Newton G, Chapman K, Aqil R, Downham R, Yan R, Merkus D, Whitlock G, Lane CAL, Cawkill D, Perrior T, Duncker DJ, Schneider MD (2021) Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals? Basic Res Cardiol 116:34. https:\/\/doi.org\/10.1007\/s00395-021-00875-7","journal-title":"Basic Res Cardiol"},{"key":"993_CR78","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0140-6736(13)61450-6","volume":"382","author":"M Thielmann","year":"2013","unstructured":"Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuh\u00e4user M, Peters J, Jakob H, Heusch G (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382:597\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(13)61450-6","journal-title":"Lancet"},{"key":"993_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00395-015-0508-3","volume":"110","author":"A Uitterdijk","year":"2015","unstructured":"Uitterdijk A, Yetgin T, Te Lintel HM, Sneep S, Krabbendam-Peters I, van Beusekom HM, Fischer TM, Cornelussen RN, Manintveld OC, Merkus D, Duncker DJ (2015) Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow. Basic Res Cardiol 110:51. https:\/\/doi.org\/10.1007\/s00395-015-0508-3","journal-title":"Basic Res Cardiol"},{"key":"993_CR80","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/cvr\/cvab370","volume":"118","author":"J van der Velden","year":"2022","unstructured":"van der Velden J, Asselbergs FW, Bakkers J, Batkai S, Bertrand L, Bezzina CR, Bot I, Brundel B, Carrier L, Chamuleau S, Ciccarelli M, Dawson D, Davidson SM, Dendorfer A, Duncker DJ, Eschenhagen T, Fabritz L, Falcao-Pires I, Ferdinandy P, Giacca M, Girao H, Gollmann-Tepekoylu C, Gyongyosi M, Guzik TJ, Hamdani N, Heymans S, Hilfiker A, Hilfiker-Kleiner D, Hoekstra AG, Hulot JS, Kuster DWD, van Laake LW, Lecour S, Leiner T, Linke WA, Lumens J, Lutgens E, Madonna R, Maegdefessel L, Mayr M, van der Meer P, Passier R, Perbellini F, Perrino C, Pesce M, Priori S, Remme CA, Rosenhahn B, Schotten U, Schulz R, Sipido KR, Sluijter JPG, van Steenbeek F, Steffens S, Terracciano CM, Tocchetti CG, Vlasman P, Yeung KK, Zacchigna S, Zwaagman D, Thum T (2022) Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC working group on cellular biology of the heart. Cardiovasc Res 118:3016\u20133051. https:\/\/doi.org\/10.1093\/cvr\/cvab370","journal-title":"Cardiovasc Res"},{"key":"993_CR81","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1093\/cvr\/cvad034","volume":"119","author":"G Vilahur","year":"2023","unstructured":"Vilahur G (2023) A primordial obstacle in cardioprotection: the answer resides in our genes. Cardiovasc Res 119:e122\u2013e124. https:\/\/doi.org\/10.1093\/cvr\/cvad034","journal-title":"Cardiovasc Res"},{"key":"993_CR82","doi-asserted-by":"publisher","first-page":"e0134264","DOI":"10.1371\/journal.pone.0134264","volume":"10","author":"A Zangrillo","year":"2015","unstructured":"Zangrillo A, Musu M, Greco T, Di Prima AL, Matteazzi A, Testa V, Nardelli P, Febres D, Monaco F, Calabro MG, Ma J, Finco G, Landoni G (2015) Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials. PLoS ONE 10:e0134264. https:\/\/doi.org\/10.1371\/journal.pone.0134264","journal-title":"PLoS ONE"},{"key":"993_CR83","doi-asserted-by":"publisher","first-page":"e027600","DOI":"10.1161\/JAHA.122.027600","volume":"12","author":"RYK Zhang","year":"2023","unstructured":"Zhang RYK, Cochran BJ, Thomas SR, Rye KA (2023) Impact of reperfusion on temporal immune cell dynamics after myocardial infarction. J Am Heart Assoc 12:e027600. https:\/\/doi.org\/10.1161\/JAHA.122.027600","journal-title":"J Am Heart Assoc"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-023-00993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-023-00993-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-023-00993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:06:20Z","timestamp":1702649180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-023-00993-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s00395-023-00993-4","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental protocols were approved by the Bioethical Committee of the district of D\u00fcsseldorf (G1868\/21) and conform to the guidelines from Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes. We followed the ARRIVE guidelines 2.0 [, ].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"23"}}